# TTI-0102 for Veterans With TBI

> **NCT04262895** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **VA Office of Research and Development**

## Conditions studied

- Mild to Moderate TBI
- Posttraumatic Stress Disorder

## Interventions

- **DRUG:** TTI-0102
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04262895
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-10-01
- **Primary completion:** 2021-10-15
- **Final completion:** 2021-10-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding withdrawn due to delay in FDA IND submission
- **Last updated:** 2021-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04262895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04262895, "TTI-0102 for Veterans With TBI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04262895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*